Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation

Biochim Biophys Acta. 2009 Jul;1793(7):1236-49. doi: 10.1016/j.bbamcr.2009.04.001. Epub 2009 Apr 14.

Abstract

Endothelial permeability is controlled by adhesive strengths which connect cells to each other through interendothelial junctions and by contractile forces associated with cytoskeleton reorganization. Phospholipase D (PLD) activation resulting in the generation of phosphatidic acid (PA) is increasingly recognized as a key event in the initiation of various cell responses. In human umbilical vein endothelial cells (HUV-EC), enhancement of intracellular PA by a variety of approaches increased the permeability of endothelial cell monolayers and induced stress fibre formation. Using adenovirus-mediated overexpression and siRNA silencing, we showed that PLD2 but not PLD1 was involved in the enhancement of basal permeability through cytoskeleton reorganization. Furthermore, PLD2 overexpression induced ERK1/2 activation and downregulated the expression of occludin, a major component of tight junctions. A substantial part of PLD2 protein was associated with the low-density caveolin-rich fractions isolated on sucrose gradients. The Raf-1 specific inhibitor GW-5074 drastically reduced hyperpermeability induced by PLD2 overexpression, and inhibited PA-mediated increase of endothelial permeability and ERK1/2 activation. On the whole, the present results demonstrate the selective role of PLD2 isoform in the control of endothelial permeability through a mechanism involving both stress fibre formation and contraction, and occludin downregulation, possibly resulting from PA-mediated activation of Raf-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Blotting, Western
  • Cells, Cultured
  • Cytoskeleton / metabolism*
  • Down-Regulation
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism*
  • Fluorescent Antibody Technique
  • Humans
  • Membrane Microdomains
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Occludin
  • Phosphatidic Acids
  • Phospholipase D / antagonists & inhibitors
  • Phospholipase D / genetics
  • Phospholipase D / metabolism*
  • Proto-Oncogene Proteins c-raf / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Umbilical Veins / cytology
  • Umbilical Veins / metabolism

Substances

  • Actins
  • Membrane Proteins
  • OCLN protein, human
  • Occludin
  • Phosphatidic Acids
  • RNA, Messenger
  • RNA, Small Interfering
  • Proto-Oncogene Proteins c-raf
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • phospholipase D2
  • Phospholipase D
  • phospholipase D1